Illudent is a biotechnology company that offers precision medicine treatment for cancer patients.
Illudent has raised $250K in total funding. The most recent round was Grant. The last funding was announced in December 2025.
Illudent's investors include Curebound.
Illudent is headquartered in San Diego, United States.
Illudent is a biotechnology company that offers precision medicine treatment for cancer patients.
Illudent is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Illudent — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/illudent. Accessed August 13, 2026.
VCBacked. (2025). Illudent — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/illudent
{{cite web |title=Illudent — Funding & Investors |url=https://www.vcbacked.co/company/illudent |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated